Pagotras 50mg (Eltrombopag) 28 Tablets
Pagotras 50 mg Tablets contains eltrombopag, a thrombopoietin receptor agonist used to treat low platelet count (thrombocytopenia) in patients with certain blood disorders. It helps the body produce more platelets, reducing the risk of bleeding.
What is Pagotras 50 mg Tablet?
Pagotras (eltrombopag) is an oral medication that stimulates platelet production in the bone marrow. It is commonly prescribed for patients who do not respond adequately to other treatments.
Uses of Pagotras 50 mg Tablets
- Treatment of Chronic Immune Thrombocytopenia (ITP)
- Management of Aplastic Anemia
- Treatment of thrombocytopenia in patients with Hepatitis C
- Reduces risk of bleeding and bruising
Benefits of Pagotras 50 mg
- Stimulates natural platelet production
- Helps reduce need for platelet transfusions
- Lowers risk of internal and external bleeding
- Improves quality of life in chronic blood disorders
- Convenient once-daily oral tablet
How Pagotras Works
Pagotras (eltrombopag) activates thrombopoietin (TPO) receptors in the bone marrow, increasing platelet production and helping maintain safer platelet levels.
Side Effects of Pagotras 50 mg Tablets
Common Side Effects
- Headache
- Nausea
- Fatigue
- Diarrhea
- Muscle pain
Serious Side Effects
- Liver function abnormalities
- Increased risk of blood clots (thrombosis)
- Cataracts with long-term use
- Severe allergic reactions (rare)
Precautions & Warnings
- Regular liver function tests required
- Avoid taking with dairy or calcium-rich foods (may reduce absorption)
- Use caution in patients with liver disease
- Not recommended during pregnancy unless prescribed
- Monitor platelet levels regularly
Dosage & Administration
- Usually taken once daily on an empty stomach
- Take at least 1–2 hours before or after meals
- Avoid taking with antacids or mineral supplements
- Follow your doctor’s instructions strictly
Packaging Information
- Pack size: 28 tablets
- Suitable for continuous therapy
Conclusion
Pagotras 50 mg Tablets (Eltrombopag) – 28’s is an effective treatment for managing thrombocytopenia in various conditions. With proper monitoring and adherence, it significantly reduces bleeding risks and improves patient outcomes.